API Product Detail
Home API Cilostazol CS-O-00531

Cilostazol

Explore technical data, documentation access, molecular information and enquiry options for this Clearsynth research product.

Product Code: CS-O-00531 API
Cilostazol
API Family
Cilostazol
Product Code
CS-O-00531

Cilostazol

Cilostazol API
Stock Status: In Stock
Live

CAT No.
CS-O-00531
CAS No.
73963-72-1
Molecular Formula
C20H27N5O2
Molecular Weight
369.47
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
73963-72-1
Product Code
CS-O-00531
M.F.
C20H27N5O2
M.W.
369.47
Smiles
O=C1NC2=C(C=C(OCCCCC3=NN=NN3C4CCCCC4)C=C2)CC1
Category
API
API Family
Cilostazol
Storage Condition
Store at refrigerator (2-8°C) for long term storage
IUPAC Name
6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one
References
"Suri; A,; et al,: J, Clin, Pharmacol,; 38; 144 (1998); Park; S,-W,; et al,: Am, J, Cardiol,; 84; 511 (1999); Tsuchikane; E,; et al,: Circulation; 100; 21 (1999);"
Synonyms
Pletaal; Pletal
Application Notes
"A potent phosphodiesterase III A (PDE3A) inhibitor (IC50=0.2uM) and inhibitor of adenosine uptake. Has antimitogeni, antithrombotic, vasodilatory and cardiotonic properties in vivo. Also affects lipid levels in vivo."
Purity by HPLC
Not less than 95%
Hazard Compound
Refer MSDS for accurate information.
Overview
"A potent phosphodiesterase III A (PDE3A) inhibitor (IC50=0.2uM) and inhibitor of adenosine uptake. Has antimitogeni, antithrombotic, vasodilatory and cardiotonic properties in vivo. Also affects lipid levels in vivo."
Downloading MSDS…
-->
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.